VENTOLIN HFA (albuterol sulfate) Inhalation Aerosol
... circumstances, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents for these patients; cardioselective beta-blockers could be considered, although they should be administered with caution. ...
... circumstances, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents for these patients; cardioselective beta-blockers could be considered, although they should be administered with caution. ...
Severe asthma guidelines - American Thoracic Society
... that further administration of omalizumab will be beneficial. Evidence from randomized trials is only available for adults. Because of the probable adverse effects of methotrexate and need for monitoring therapy we suggest that any use of methotrexate is limited to specialized centres and only in pa ...
... that further administration of omalizumab will be beneficial. Evidence from randomized trials is only available for adults. Because of the probable adverse effects of methotrexate and need for monitoring therapy we suggest that any use of methotrexate is limited to specialized centres and only in pa ...
Ezetimibe and rosuvastatin - Therapeutic Goods Administration (TGA)
... The justification for the proposed composite pack was approved by the TGA (19 March ...
... The justification for the proposed composite pack was approved by the TGA (19 March ...
Complete Issue - Journal of Crohn`s and Colitis
... © 2015 European Crohn’s and Colitis Organisation. Published by Oxford University Press. All rights reserved. This journal and the individual contributions contained in it are protected under copyright by the European Crohn’s and Colitis Organisation (ECCO) and the following terms and conditions app ...
... © 2015 European Crohn’s and Colitis Organisation. Published by Oxford University Press. All rights reserved. This journal and the individual contributions contained in it are protected under copyright by the European Crohn’s and Colitis Organisation (ECCO) and the following terms and conditions app ...
terminology guidelines glaucoma
... the effect of topical ocular hypotensive medication in delaying or preventing the onset of glaucoma in patients with ocular hypertension (OH)19. 1,636 patients were recruited. Randomization was between treatment with IOP lowering medications and no treatment. The treatment goal was to lower the IOP ...
... the effect of topical ocular hypotensive medication in delaying or preventing the onset of glaucoma in patients with ocular hypertension (OH)19. 1,636 patients were recruited. Randomization was between treatment with IOP lowering medications and no treatment. The treatment goal was to lower the IOP ...
Product Information - Therapeutic Goods Administration
... cholesterol absorption by 54 %, compared with placebo. A series of preclinical studies was performed to determine the selectivity of ezetimibe for inhibiting cholesterol absorption. Ezetimibe inhibited the absorption of [14C]-cholesterol with no effect on the absorption of triglycerides, fatty acids ...
... cholesterol absorption by 54 %, compared with placebo. A series of preclinical studies was performed to determine the selectivity of ezetimibe for inhibiting cholesterol absorption. Ezetimibe inhibited the absorption of [14C]-cholesterol with no effect on the absorption of triglycerides, fatty acids ...
Philippine College of Chest Physicians
... rhinitis, and eczema among school children. One hundred fifty five centers in 56 countries participated, including the Philippines.1 More than 450,000 children were interviewed using a one-page written questionnaire or a video asthma questionnaire. The study showed that the prevalence of asthma symp ...
... rhinitis, and eczema among school children. One hundred fifty five centers in 56 countries participated, including the Philippines.1 More than 450,000 children were interviewed using a one-page written questionnaire or a video asthma questionnaire. The study showed that the prevalence of asthma symp ...
Prescribing Adult Intravenous Nutrition
... directly into patients’ veins. It is used in patients whose gastrointestinal absorption of food and/or fluids is inadequate, unsafe or inaccessible. Infusing a mixture of nutrients and fluid, however, is not without risk. The placement of an intravenous catheter into a large central vein can cause t ...
... directly into patients’ veins. It is used in patients whose gastrointestinal absorption of food and/or fluids is inadequate, unsafe or inaccessible. Infusing a mixture of nutrients and fluid, however, is not without risk. The placement of an intravenous catheter into a large central vein can cause t ...
FLUCONAZOLE INJECTION, USP
... of fluconazole-associated hepatotoxicity, no obvious relationship to total daily dose, duration of therapy, sex or age of the patient has been observed. Fluconazole hepatotoxicity has usually, but not always been reversible on discontinuation of therapy. Patients who develop abnormal liver function ...
... of fluconazole-associated hepatotoxicity, no obvious relationship to total daily dose, duration of therapy, sex or age of the patient has been observed. Fluconazole hepatotoxicity has usually, but not always been reversible on discontinuation of therapy. Patients who develop abnormal liver function ...
Committee papers
... The results of the PARADIGM-HF trial are not generalisable to clinical practice in England (see clinical effectiveness key issues). The mortality in the trial (and in the model) portrays a scenario representative of the use of sacubitril valsartan for established patients. Less than 10% of patie ...
... The results of the PARADIGM-HF trial are not generalisable to clinical practice in England (see clinical effectiveness key issues). The mortality in the trial (and in the model) portrays a scenario representative of the use of sacubitril valsartan for established patients. Less than 10% of patie ...
Psoriasis - Wikipedia, the free encyclopedia
... The cause of psoriasis is not fully understood. There are two main hypotheses about the process that occurs in the development of the disease. The first considers psoriasis as primarily a disorder of excessive growth and reproduction of skin cells. The problem is simply seen as a fault of the epider ...
... The cause of psoriasis is not fully understood. There are two main hypotheses about the process that occurs in the development of the disease. The first considers psoriasis as primarily a disorder of excessive growth and reproduction of skin cells. The problem is simply seen as a fault of the epider ...
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report
... quality. Many infants and preschool children experience recurrent episodes of bronchial symptoms, especially wheezing and cough, beginning at a few months of age, mainly during a lower respiratory tract infection, and since a clinical diagnosis of asthma usually can be made with certainty by age 5, ...
... quality. Many infants and preschool children experience recurrent episodes of bronchial symptoms, especially wheezing and cough, beginning at a few months of age, mainly during a lower respiratory tract infection, and since a clinical diagnosis of asthma usually can be made with certainty by age 5, ...
Diagnosis and treatment of asthma in childhood: a
... quality. Many infants and preschool children experience recurrent episodes of bronchial symptoms, especially wheezing and cough, beginning at a few months of age, mainly during a lower respiratory tract infection, and since a clinical diagnosis of asthma usually can be made with certainty by age 5, ...
... quality. Many infants and preschool children experience recurrent episodes of bronchial symptoms, especially wheezing and cough, beginning at a few months of age, mainly during a lower respiratory tract infection, and since a clinical diagnosis of asthma usually can be made with certainty by age 5, ...
this issue
... in others. This likely explains why there are different clinical venous categories of CVD in patients with similar venous hemodynamics.14 It becomes evident that until we develop diagnostic techniques to assess these important end points, classification systems that include pathophysiology as part o ...
... in others. This likely explains why there are different clinical venous categories of CVD in patients with similar venous hemodynamics.14 It becomes evident that until we develop diagnostic techniques to assess these important end points, classification systems that include pathophysiology as part o ...
sulfamethoxazole/trimethoprim
... ) Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim. A single-strength (SS) tablet contains sulfamethoxazole 400 milligrams (mg)/trimethoprim 80 mg. A double-strength (DS) tablet contains sulfamethoxazole 800 mg/trimethoprim 160 mg. A 5milliliter (mL) vial of the intravenous form c ...
... ) Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim. A single-strength (SS) tablet contains sulfamethoxazole 400 milligrams (mg)/trimethoprim 80 mg. A double-strength (DS) tablet contains sulfamethoxazole 800 mg/trimethoprim 160 mg. A 5milliliter (mL) vial of the intravenous form c ...
Report on the Deliberation Results March 6, 2007 Evaluation and
... IFL regimen (irinotecan hydrochloride + 5-FU/LV) in patients with colorectal cancer were conducted. A phase III study of bevacizumab in combination with IFL regimen in patients with colorectal cancer was undertaken in September 2000. Based on these clinical study data, a new drug application for bev ...
... IFL regimen (irinotecan hydrochloride + 5-FU/LV) in patients with colorectal cancer were conducted. A phase III study of bevacizumab in combination with IFL regimen in patients with colorectal cancer was undertaken in September 2000. Based on these clinical study data, a new drug application for bev ...
Diagnosis and Treatment of Pleural Effusion
... Methods Used to Investigate Pleural Disease Medical History Patients with pleural effusions should be studied systematically. As a first step a complete medical history should be taken with special emphasis on the patient’s history of exposure to asbestos, current and recent medications, and the pri ...
... Methods Used to Investigate Pleural Disease Medical History Patients with pleural effusions should be studied systematically. As a first step a complete medical history should be taken with special emphasis on the patient’s history of exposure to asbestos, current and recent medications, and the pri ...
TRI NEWSLETTER Research Highlights News
... duration of 4 years, over 150 experts from 26 European countries will work together to understand the tinnitus heterogeneity. Organized in 5 workgroups (Clinical, Database, Neuroimaging, Genetics and Outcome Measures) the researchers and clinicians will meet several times every year to develop new w ...
... duration of 4 years, over 150 experts from 26 European countries will work together to understand the tinnitus heterogeneity. Organized in 5 workgroups (Clinical, Database, Neuroimaging, Genetics and Outcome Measures) the researchers and clinicians will meet several times every year to develop new w ...
Migraine with aura - Choose your language | Know Pain
... 1. At least one aura symptom spreads gradually over ≥5 minutes, and/or two or more symptoms occur in succession 2. Each individual aura symptom lasts 5 to 60 minutes 3. At least one aura symptom is unilateral 4. The aura is accompanied, or followed within 60 minutes, by headache D. Not better accoun ...
... 1. At least one aura symptom spreads gradually over ≥5 minutes, and/or two or more symptoms occur in succession 2. Each individual aura symptom lasts 5 to 60 minutes 3. At least one aura symptom is unilateral 4. The aura is accompanied, or followed within 60 minutes, by headache D. Not better accoun ...
Sclerotherapy for leg varicose veins
... injecting a chemical irritant (sclerosant) into the veins with a small needle. The sclerosant causes inflammation, thrombosis, and subsequent fibrosis of the vein. The therapeutic outcome and safety of sclerotherapy depend on careful pre-treatment evaluation of each patient and on the provider’s lev ...
... injecting a chemical irritant (sclerosant) into the veins with a small needle. The sclerosant causes inflammation, thrombosis, and subsequent fibrosis of the vein. The therapeutic outcome and safety of sclerotherapy depend on careful pre-treatment evaluation of each patient and on the provider’s lev ...
- ORCA
... performed at home by patients and their relatives. Increasing numbers of patients are requiring treatment for this disease and therefore clinicians are calling for more patients to use peritoneal dialysis. However, the literature revealed only a small number of qualitative studies that considered pa ...
... performed at home by patients and their relatives. Increasing numbers of patients are requiring treatment for this disease and therefore clinicians are calling for more patients to use peritoneal dialysis. However, the literature revealed only a small number of qualitative studies that considered pa ...
Exercise-induced bronchoconstriction update-2016
... Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and ACAAI have jointly accepted responsibility for establishing ‘‘Exercise-induced bronchoconstriction update—2016.’’ This i ...
... Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology. The AAAAI and ACAAI have jointly accepted responsibility for establishing ‘‘Exercise-induced bronchoconstriction update—2016.’’ This i ...
Hypnosis and Hypnotherapy Citations
... defective, owing to a lack of good evaluative design and poor use of statistics. Most examined studies are of a single case or of less than 5 patients, which does not allow general conclusions to be drawn. The use of hypnosis has been found to be particularly beneficial in treating psychosomatic dis ...
... defective, owing to a lack of good evaluative design and poor use of statistics. Most examined studies are of a single case or of less than 5 patients, which does not allow general conclusions to be drawn. The use of hypnosis has been found to be particularly beneficial in treating psychosomatic dis ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.